DE602005014990D1 - Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn - Google Patents

Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn

Info

Publication number
DE602005014990D1
DE602005014990D1 DE602005014990T DE602005014990T DE602005014990D1 DE 602005014990 D1 DE602005014990 D1 DE 602005014990D1 DE 602005014990 T DE602005014990 T DE 602005014990T DE 602005014990 T DE602005014990 T DE 602005014990T DE 602005014990 D1 DE602005014990 D1 DE 602005014990D1
Authority
DE
Germany
Prior art keywords
peptide
crohn
morbus crohn
disease
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005014990T
Other languages
English (en)
Inventor
Mikio Niwa
Katsuhiko Matsuo
Keiichi Mitsuyama
Michio Sata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toagosei Co Ltd
Kurume University
Original Assignee
Toagosei Co Ltd
Kurume University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toagosei Co Ltd, Kurume University filed Critical Toagosei Co Ltd
Publication of DE602005014990D1 publication Critical patent/DE602005014990D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005014990T 2004-08-05 2005-04-26 Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn Active DE602005014990D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004229171 2004-08-05
PCT/JP2005/007857 WO2006013661A1 (ja) 2004-08-05 2005-04-26 クローン病抗体エピトープペプチド及びクローン病の検査試薬

Publications (1)

Publication Number Publication Date
DE602005014990D1 true DE602005014990D1 (de) 2009-07-30

Family

ID=35786960

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005014990T Active DE602005014990D1 (de) 2004-08-05 2005-04-26 Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn

Country Status (9)

Country Link
US (1) US7985831B2 (de)
EP (1) EP1780215B1 (de)
JP (1) JP4597132B2 (de)
KR (1) KR101159626B1 (de)
CN (2) CN101031581A (de)
AT (1) ATE433991T1 (de)
DE (1) DE602005014990D1 (de)
ES (1) ES2328261T3 (de)
WO (1) WO2006013661A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5660027B2 (ja) * 2009-03-05 2015-01-28 味の素株式会社 クローン病診断試薬
US20110177525A1 (en) * 2010-01-19 2011-07-21 Predictive Biosciences, Inc. Antibodies and methods of diagnosing diseases
WO2011130546A1 (en) * 2010-04-14 2011-10-20 Inova Diagnostics, Inc. Methods for differentiating between crohn's disease and other inflammatory bowel conditions
GB2506870B (en) * 2012-10-09 2014-11-12 Gos Networks Ltd Method for the reduction of signalling traffic on mobile devices
IT201600090052A1 (it) * 2016-09-06 2018-03-06 Univ Degli Studi Padova Peptide per la diagnosi differenziale della Malattia di Crohn
CN110256541A (zh) * 2019-05-15 2019-09-20 山西瑞豪生物科技有限公司 一种检测克隆恩氏病血清抗体的多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001055355A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
JPWO2002088175A1 (ja) 2001-04-24 2004-08-19 大塚製薬株式会社 クローン病抗体結合性ペプチド及びクローン病の検査方法

Also Published As

Publication number Publication date
JP4597132B2 (ja) 2010-12-15
US7985831B2 (en) 2011-07-26
WO2006013661A1 (ja) 2006-02-09
ATE433991T1 (de) 2009-07-15
KR101159626B1 (ko) 2012-07-19
JPWO2006013661A1 (ja) 2008-05-01
EP1780215A4 (de) 2007-11-14
CN101654474A (zh) 2010-02-24
KR20070037635A (ko) 2007-04-05
CN101654474B (zh) 2012-11-07
US20090170115A1 (en) 2009-07-02
ES2328261T3 (es) 2009-11-11
EP1780215A1 (de) 2007-05-02
CN101031581A (zh) 2007-09-05
EP1780215B1 (de) 2009-06-17

Similar Documents

Publication Publication Date Title
DE602005014990D1 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
IN2015KN00290A (de)
MX2007013626A (es) Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos.
ATE542920T1 (de) Modifiziertes menschliches wachstumshormon
GEP20105111B (en) Rage fusion proteins and methods of use
RU2016146198A (ru) Терапевтические dll4-связывающие белки
MX2019005415A (es) Anticuerpos de il-6 y uso de los mismos.
RU2011106744A (ru) Инсулин, стабилизированный галогеном
DE602007009954D1 (de) Verfahren zur identifizierung von polypeptid-targets
EA201100072A1 (ru) Новые композиции и способы
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
WO2006125201A3 (en) Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
NZ601980A (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
ATE493432T1 (de) Gewinnung von hitzeschockproteinen
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
WO2005004894A3 (en) Methods for increasing cell and tissue viability
HK1106001A1 (en) Method of screening for a carnitine transporter agonist or antagonist and its uses
DE602004013752D1 (de) Oberflächenprotein aus Neisserien
WO2006000464A3 (de) Verfahren zum auffinden schmerzrelevanter substanzen unter verwendung schmerzrelevanter proteine
WO2010133806A3 (fr) Peptides marques et leur utilisation pour le dosage d'irap circulant
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
WO2002075317A3 (en) Screening for drugs against disorders associated with schizophrenia
WO2007020405A3 (en) Integrin i-domain binding peptides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition